Gradient Investments LLC Astrazeneca PLC Transaction History
Gradient Investments LLC
- $3.78 Billion
- Q4 2024
A detailed history of Gradient Investments LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Gradient Investments LLC holds 7,272 shares of AZN stock, worth $536,746. This represents 0.01% of its overall portfolio holdings.
Number of Shares
7,272
Previous 7,071
2.84%
Holding current value
$536,746
Previous $550,000
13.45%
% of portfolio
0.01%
Previous 0.01%
Shares
28 transactions
Others Institutions Holding AZN
# of Institutions
1,355Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.45 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.03 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.77 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.73 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.77 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $229B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...